<PAGE> 1
[HOLLAND & HART LLP LETTERHEAD]
September 17, 1996
Mr. Jeff Epstein
Branch 8, Division of Corporation Finance
Mail Stop 7-5
Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, D.C. 20549
Re: UroQuest Corporation; Registration Statement on Form 8-A;
File No. 0-20963; Request for Withdrawal
-----------------------------------------------------------------
Dear Jeff:
Pursuant to our telephone conferences yesterday, enclosed please find
UroQuest Corporation's request for withdrawal with respect to the
above-referenced Registration Statement.
If there are any questions with the request, please do not hesitate to
call.
Very truly yours,
/s/ David G. Angerbauer
David G. Angerbauer
of Holland & Hart LLP
DGA/tb
Enclosure
cc: David R. Rudd, Esq.
Mr. Eric B. Hale
<PAGE> 2
[UROQUEST CORPORATION LETTERHEAD]
September 17, 1996
Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, D.C. 20549
Re: UroQuest Corporation
Registration Statement on Form 8-A
File No. 0-20963
Request for Withdrawal
Ladies & Gentlemen:
UroQuest Corporation (the "Company") hereby requests withdrawal of the
above-referenced Registration Statement (the "Registration Statement") under
the Securities Exchange Act of 1934, as amended, effective immediately or at
such other time as is necessary to prevent the Registration Statement from
becoming effective.
At the time the Registration Statement was filed, the Company
contemporaneously filed a Registration Statement on Form S-1, Reg. No.
333-07277 (the "Form S-1"), under the Securities Act of 1933, as amended, and
requested concurrent effectiveness. The Form S-1, which relates to the
Company's contemplated initial public offering, has not yet become effective
and it is likely that the Company will seek to withdraw the Form S-1 pursuant
to Rule 477 in the near-future. It was never intended that the Registration
Statement become effective without the simultaneous effectiveness of the
Form S-1.
Should you have any questions or require any further information, please
contact the undersigned or David G. Angerbauer of Holland & Hart, counsel to
the Company, at (801) 595-7800.
Sincerely,
/s/ Eric B. Hale
Eric B. Hale
President and Chief Executive Officer
EBH:tb
[ADDRESS LOGO]
